By: Benzinga
UPDATE: Deutsche Bank Raises PT to $46 on Tenet Healthcare on Solid EBITDA Visibility
Deutsche Bank maintained Tenet Healthcare (NYSE: THC ) with a BUy rating and raised the price target from $43.00 to $46.00. Deutsche Bank noted, "We continue to believe THC has solid visibility into its 2013 EBITDA growth. Management is guiding to +14% yoy EBITDA growth at the mid-point of
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here